Cocrystal Pharma Inc (COCP)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $18.88M
Last updated: Nov 17, 2026 at 10:48 AM ET
Cocrystal Pharma Inc (COCP) Earnings: Report Dates and Results
Cocrystal Pharma (COCP) is expected to report earnings on Mar 29, 2027. In the quarter ended Jun 30, 2026, Cocrystal Pharma reported EPS of -$0.23, below the -$0.17 estimate. It beat the EPS estimate in 6 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
COCP has an expected report date of Mar 29, 2027.
Earnings History
Of the 33 quarters below that had an estimate, COCP beat 23, missed 8 and matched 2. The widest gap in the table came in the quarter ended Dec 31, 2018, when EPS landed 525.00% above the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | -$0.23 | -$0.17 | -$0.18 - -$0.15 | -35.29% | Miss | N/A | 2 | 0 up, 0 down | Aug 13, 2026 | $105000 |
| Mar 31, 2026 | -$0.17 | -$0.15 | -$0.16 - -$0.14 | -13.33% | Miss | N/A | 2 | 0 up, 0 down | May 15, 2026 | $225000 |
| Dec 31, 2025 | -$0.17 | -$0.18 | -$0.18 - -$0.17 | +2.86% | Beat | N/A | 2 | 2 up, 0 down | Dec 31, 2025 | N/A |
| Sep 30, 2025 | -$0.19 | -$0.21 | -$0.22 - -$0.21 | +9.52% | Beat | N/A | 2 | 1 up, 0 down | Nov 14, 2025 | N/A |
| Jun 30, 2025 | -$0.20 | -$0.30 | -$0.44 - -$0.20 | +33.33% | Beat | N/A | 3 | 0 up, 0 down | Aug 14, 2025 | N/A |
| Mar 31, 2025 | -$0.23 | -$0.52 | -$0.60 - -$0.41 | +55.77% | Beat | N/A | 2 | 0 up, 0 down | May 15, 2025 | N/A |
| Dec 31, 2024 | -$0.32 | -$0.53 | -$0.62 - -$0.47 | +39.62% | Beat | N/A | 3 | 1 up, 0 down | Mar 31, 2025 | $136000 |
| Sep 30, 2024 | -$0.49 | -$0.57 | -$0.59 - -$0.55 | +14.04% | Beat | N/A | 3 | 0 up, 0 down | Nov 13, 2024 | N/A |
| Jun 30, 2024 | -$0.53 | -$0.48 | -$0.56 - -$0.42 | -10.42% | Miss | N/A | 3 | 0 up, 0 down | Aug 14, 2024 | N/A |
| Mar 31, 2024 | -$0.39 | -$0.56 | -$0.56 - -$0.52 | +30.36% | Beat | N/A | 2 | 0 up, 0 down | May 13, 2024 | N/A |
| Dec 31, 2023 | -$0.44 | -$0.60 | -$0.66 - -$0.55 | +26.67% | Beat | N/A | 3 | 0 up, 0 down | Mar 28, 2024 | $144000 |
| Sep 30, 2023 | -$0.41 | -$0.65 | -$0.65 - -$0.45 | +36.92% | Beat | N/A | 3 | 0 up, 0 down | Nov 13, 2023 | N/A |
| Jun 30, 2023 | -$0.50 | -$0.47 | -$0.69 - -$0.47 | -6.38% | Miss | N/A | 3 | 0 up, 0 down | Aug 14, 2023 | N/A |
| Mar 31, 2023 | -$0.64 | -$0.70 | N/A | +8.57% | Beat | N/A | 2 | 0 up, 0 down | May 15, 2023 | N/A |
| Dec 31, 2022 | -$0.55 | -$0.73 | -$0.74 - -$0.71 | +24.66% | Beat | N/A | 3 | 0 up, 0 down | Mar 29, 2023 | N/A |
| Sep 30, 2022 | -$0.70 | -$0.49 | N/A | -42.86% | Miss | N/A | 3 | 0 up, 0 down | Nov 14, 2022 | N/A |
| Jun 30, 2022 | -$0.46 | -$0.52 | -$0.60 - -$0.48 | +11.54% | Beat | N/A | 3 | 0 up, 0 down | Aug 15, 2022 | N/A |
| Mar 31, 2022 | -$0.48 | -$0.42 | -$0.48 - -$0.36 | -14.29% | Miss | N/A | 2 | 0 up, 0 down | May 11, 2022 | N/A |
| Dec 31, 2021 | -$0.48 | -$0.48 | -$0.48 - -$0.48 | 0.00% | In line | N/A | 3 | 0 up, 0 down | Mar 23, 2022 | $5427 |
| Sep 30, 2021 | -$0.48 | -$0.48 | -$0.48 - -$0.36 | 0.00% | In line | N/A | 2 | N/A | Nov 15, 2021 | N/A |
| Jun 30, 2021 | -$0.48 | -$0.42 | -$0.48 - -$0.36 | -14.29% | Miss | N/A | 2 | N/A | Aug 16, 2021 | N/A |
| Mar 31, 2021 | -$0.48 | -$0.54 | -$0.60 - -$0.48 | +11.11% | Beat | N/A | 2 | N/A | May 17, 2021 | N/A |
| Dec 31, 2020 | -$0.24 | -$0.48 | -$0.48 - -$0.48 | +50.00% | Beat | N/A | 1 | N/A | Mar 17, 2021 | $510000 |
| Sep 30, 2020 | -$0.57 | -$0.60 | -$0.60 - -$0.60 | +5.00% | Beat | N/A | 1 | N/A | Nov 16, 2020 | $489000 |
| Jun 30, 2020 | -$0.79 | -$0.48 | -$0.48 - -$0.48 | -64.58% | Miss | N/A | 1 | N/A | Aug 6, 2020 | $554000 |
| Mar 31, 2020 | -$0.57 | -$0.96 | -$0.96 - -$0.96 | +40.63% | Beat | N/A | 1 | N/A | May 14, 2020 | $461000 |
| Dec 31, 2019 | -$0.60 | -$0.84 | -$0.84 - -$0.84 | +28.57% | Beat | -276.5% | 1 | N/A | Mar 27, 2020 | $402000 |
| Sep 30, 2019 | -$0.87 | -$0.96 | -$0.96 - -$0.96 | +9.38% | Beat | N/A | 1 | N/A | Nov 12, 2019 | $492000 |
| Jun 30, 2019 | -$0.81 | -$0.84 | -$0.84 - -$0.84 | +3.57% | Beat | N/A | 1 | N/A | Aug 9, 2019 | $592000 |
| Mar 31, 2019 | -$0.87 | -$0.96 | -$0.96 - -$0.96 | +9.38% | Beat | N/A | 1 | N/A | Apr 1, 2019 | $5.08M |
| Dec 31, 2018 | $0.34 | -$0.08 | N/A | +525.00% | Beat | +61.9% | N/A | N/A | Dec 31, 2018 | N/A |
| Sep 30, 2018 | -$0.72 | -$0.96 | N/A | +25.00% | Beat | N/A | N/A | N/A | Nov 12, 2018 | N/A |
| Jun 30, 2018 | -$0.60 | -$0.84 | N/A | +28.57% | Beat | N/A | N/A | N/A | Aug 9, 2018 | N/A |
| Mar 31, 2018 | -$0.06 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 11, 2018 | N/A |
| Dec 31, 2017 | $0.21 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 21, 2018 | N/A |
| Sep 30, 2017 | -$0.09 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 8, 2017 | N/A |
| Jun 30, 2017 | -$0.04 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 8, 2017 | N/A |
| Mar 31, 2017 | -$0.11 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Apr 27, 2017 | N/A |
| Dec 31, 2016 | -$33.15 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Dec 31, 2016 | N/A |
| Sep 30, 2016 | -$0.96 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 9, 2016 | N/A |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$0.79, after -$1.73 the year before. It was -$37.83 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$0.79 | N/A |
| Dec 31, 2024 | -$1.73 | N/A |
| Dec 31, 2023 | -$1.99 | N/A |
| Dec 31, 2022 | -$2.19 | N/A |
| Dec 31, 2021 | -$1.92 | N/A |
| Dec 31, 2020 | -$2.17 | N/A |
| Dec 31, 2019 | -$3.15 | N/A |
| Dec 31, 2018 | -$1.04 | N/A |
| Dec 31, 2017 | -$0.03 | N/A |
| Dec 31, 2016 | -$37.83 | N/A |
Frequently Asked Questions About COCP
When is Cocrystal Pharma's next earnings date?
Cocrystal Pharma's next earnings report is expected for Mar 29, 2027.
Did COCP beat earnings estimates last quarter?
No. Cocrystal Pharma reported EPS of -$0.23 for the quarter ended Jun 30, 2026, below the -$0.17 estimate by 35.29%.
What EPS do analysts expect from COCP next quarter?
The consensus EPS estimate for Cocrystal Pharma for the quarter ending Dec 31, 2026 is -$0.15 from 5 analysts.
How often does COCP beat earnings estimates?
Cocrystal Pharma beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of +13.31%.
COCP pages: Overview, Earnings, Forecast, Financials, Competitors, Government Contracts